UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
June 28, 2024
Accession Number:
0001104659-24-075846
Submission Type:
POS AM
CIK:
0001730430
Company Name:
Kiniksa Pharmaceuticals International, plc
File Number:
333-264746